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BACKGROUND: Chronic disease represents a large and growing burden to the health care system 
worldwide. One method of managing this burden is the use of app-based interventions; however attrition, 
defined as lack of patient use of the intervention, is an issue for these interventions. While many apps 
have been developed, there is some evidence that they have significant issues with sustained use, with up 
to 98% of people only using the app for a short time before dropping out and/or dropping use down to the 
point where the app is no longer effective at helping to manage disease. OBJECTIVE: Our objectives are 
to systematically appraise and perform a meta-analysis on dropout rates in apps for chronic disease and 
to qualitatively synthesize possible reasons for these dropout rates that could be addressed in future 
interventions. METHODS: MEDLINE (Medical Literature Analysis and Retrieval System Online), PubMed, 
Cochrane CENTRAL (Central Register of Controlled Trials), and Embase were searched from 2003 to the 
present to look at mobile health (mHealth) and attrition or dropout. Studies, either randomized controlled 
trials (RCTs) or observational trials, looking at chronic disease with measures of dropout were included. 
Meta-analysis of attrition rates was conducted in Stata, version 15.1 (StataCorp LLC). Included studies 
were also qualitatively synthesized to examine reasons for dropout and avenues for future research. 
RESULTS: Of 833 studies identified in the literature search, 17 were included in the review and meta-
analysis. Out of 17 studies, 9 (53%) were RCTs and 8 (47%) were observational trials, with both types 
covering a range of chronic diseases. The pooled dropout rate was 43% (95% CI 29-57), with 
observational studies having a higher dropout rate (49%, 95% CI 27-70) than RCTs in more controlled 
scenarios, which only had a 40% dropout rate (95% CI 16-63). The studies were extremely varied, which is 
represented statistically in the high degree of heterogeneity (I2>99%). Qualitative synthesis revealed a 
range of reasons relating to attrition from app-based interventions, including social, demographic, and 
behavioral factors that could be addressed. CONCLUSIONS: Dropout rates in mHealth interventions are 
high, but possible areas to minimize attrition exist. Reducing dropout rates will make these apps more 
effective for disease management in the long term. TRIAL REGISTRATION: International Prospective 
Register of Systematic Reviews (PROSPERO) CRD42019128737; https://www.crd.york.ac.uk/prospero/
display_record.php?ID=CRD42019128737. 
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Abstract
Background: Chronic disease represents a large and growing burden to the health care system worldwide. One method of
managing this burden is the use of app-based interventions; however attrition, defined as lack of patient use of the intervention,
is an issue for these interventions. While many apps have been developed, there is some evidence that they have significant issues
with sustained use, with up to 98% of people only using the app for a short time before dropping out and/or dropping use down
to the point where the app is no longer effective at helping to manage disease.
Objective: Our objectives are to systematically appraise and perform a meta-analysis on dropout rates in apps for chronic disease
and to qualitatively synthesize possible reasons for these dropout rates that could be addressed in future interventions.
Methods: MEDLINE (Medical Literature Analysis and Retrieval System Online), PubMed, Cochrane CENTRAL (Central
Register of Controlled Trials), and Embase were searched from 2003 to the present to look at mobile health (mHealth) and attrition
or dropout. Studies, either randomized controlled trials (RCTs) or observational trials, looking at chronic disease with measures
of dropout were included. Meta-analysis of attrition rates was conducted in Stata, version 15.1 (StataCorp LLC). Included studies
were also qualitatively synthesized to examine reasons for dropout and avenues for future research.
Results: Of 833 studies identified in the literature search, 17 were included in the review and meta-analysis. Out of 17 studies,
9 (53%) were RCTs and 8 (47%) were observational trials, with both types covering a range of chronic diseases. The pooled
dropout rate was 43% (95% CI 29-57), with observational studies having a higher dropout rate (49%, 95% CI 27-70) than RCTs
in more controlled scenarios, which only had a 40% dropout rate (95% CI 16-63). The studies were extremely varied, which is
represented statistically in the high degree of heterogeneity (I2>99%). Qualitative synthesis revealed a range of reasons relating
to attrition from app-based interventions, including social, demographic, and behavioral factors that could be addressed.
Conclusions: Dropout rates in mHealth interventions are high, but possible areas to minimize attrition exist. Reducing dropout
rates will make these apps more effective for disease management in the long term.
Trial Registration: International Prospective Register of Systematic Reviews (PROSPERO) CRD42019128737;
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019128737
(J Med Internet Res 2020;22(9):e20283) doi: 10.2196/20283
KEYWORDS
chronic disease; mHealth; mobile apps; attrition; dropout
J Med Internet Res 2020 | vol. 22 | iss. 9 | e20283 | p. 1http://www.jmir.org/2020/9/e20283/
(page number not for citation purposes)




Chronic diseases are a large and growing issue worldwide, with
rates increasing dramatically in recent years, including infectious
diseases that are now managed chronically, such as HIV. One
example is diabetes, with global prevalence nearly doubling
from less than 5% in the 1990s to more than 8% today [1]. As
with other chronic diseases, the economic and social cost of
diabetes is enormous, with large direct health care costs often
eclipsed by the societal impacts of the disease [1,2]. This has
led to a large body of research focusing on how to prevent and
manage these diseases, with many recommendations now
advising moving from a model of care that is medically focused
to patient-centric and community-focused care [3]. However,
there are many difficulties in implementing programs for chronic
disease prevention and care, in particular, the challenges posed
by catering to a large, diverse, and growing population of people
requiring these services [1,4]. One such difficulty is the dropout
rate, or attrition, whereby patients discontinue use of
interventions either entirely or enough that the benefit from the
intervention is negligible. This is an area of particular concern
for new technological innovations, such as mobile phone apps.
The management of chronic disease is often complex. Patients
may be on numerous medications, follow strict dietary regimens,
and have lifestyle goals to fulfil to optimally manage their
disease [5]. Professional assistance from health
workers—doctors, educators, dieticians, and others—is an
important component of this management, but increasingly,
internat ional  evidence has  shown that
self-management—empowering patients to manage their own
care—is another effective way to improve outcomes [6-8].
Self-management interventions range from providing
educational materials to highly supportive, multifaceted
programs that include a variety of measures [7]. One method
of self-management assistance that is increasingly popular is
providing web-based eHealth or mobile apps (ie, mobile health
[mHealth]) to people in order to assist in their management of
their disease [9]. These interventions have demonstrated efficacy
in terms of markers for management, with a recent systematic
review finding that, although the evidence is preliminary,
mHealth interventions are effective in reducing weight and
glycated hemoglobin in people with diabetes [10]. Another
recent review looking only at the efficacy of mobile apps for
diabetes care found that there was limited evidence supporting
the effectiveness of diabetes apps to improve blood glucose
markers for people with diabetes [11]. Overall, there is a
growing body of evidence that mHealth interventions, and apps
in particular, may be an effective method of promoting
self-management in patients.
However, a major barrier to patient care in the use of mHealth
interventions is attrition. Previous research has identified that
up to 80% of all participants in mHealth interventions may
engage in only minimal use of these interventions, defined as
logging in to the service less than twice, and only a small
fraction of users consistently use the intervention long term
[12,13]. While clinical trials often report 70% or higher
retention, these are often short in duration, some fewer than two
months, and may not represent the situation in real-world use
[10]. One observational trial of app usage in a large real-world
cohort found that only 2% had sustained continuous use of the
kind that would be expected to improve clinical outcomes [14].
If only 2% of people who download an app actually use it, there
is clearly minimal benefit for the majority. Demonstrating that
mHealth interventions are effective in clinical trials is not
enough: retention in real-world settings is a necessary
precondition for these interventions to be considered effective.
This paper presents a systematic review and meta-analysis into
the rate and causes of dropout in mHealth interventions for
diabetes and other chronic health issues. This is divided into
clinical trials and observational research studies in order to
estimate the rates in both controlled and uncontrolled settings
and to estimate the effect both in studies with a large support
network to prevent attrition and in the more real-world
experience that might be expected when these apps are actually
rolled out into clinical practice. These were also qualitatively
synthesized.
Methods
A reproducible strategy was used to identify studies examining
mHealth interventions for self-management of chronic disease,
either mobile app based or internet based. Studies were
identified by electronically searching MEDLINE (Medical
Literature Analysis and Retrieval System Online), PubMed,
Cochrane CENTRAL (Central Register of Controlled Trials),
and Embase from 2003 to the present day. Search terms are
fully outlined below and are loosely based on previous
systematic reviews looking at similar topics [15]. Searches were
performed in June 2019 by GMK, and duplicates were excluded
using Microsoft Excel 2013 and EndNote, version 8.0
(Clarivate).
Electronic downloads of searched titles were then performed
using the data collection process for each individual database,
with titles being screened by GMK and SR against inclusion
criteria to determine eligibility. Abstracts were then reviewed
by these two reviewers independently. Any disagreements were
adjudicated between the two authors. References from included
studies were also assessed to identify further trials for inclusion.
Both experimental and quasi-experimental study designs were
included in this review. As the analysis is based on a secondary
endpoint (ie, attrition), no formal risk-of-bias tool was used to
assess the quality of included studies.
For the meta-analysis, the total rate of dropout was extracted
from each study, as well as the number of participants in the
control and intervention groups. The primary summary measure
was the rate of dropout in these trials.
Eligibility criteria for inclusion of studies are as
follows—studies must meet all criteria:
1. Published in English.
2. Addressed to an adult population (≥18 years of age).
3. Either randomized controlled trials (RCTs) or observational
interventions (ie, case control or cohort).
4. Look at app usage in chronic disease.
5. Include a measure of dropout and attrition.
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A systematic narrative synthesis was produced to describe the
included studies and their findings relating to dropout. This
narrative synthesis reviewed the findings from all included
studies and provided an overall summation of the subject matter.
Stata, version 15.1 (StataCorp LLC), was used to perform the
meta-analysis of the included studies, using the metaprop
command, with results pooled from RCTs looking at the rate
of dropout in clinical trials. There was also a second
meta-analysis, by trial type: observational versus RCT. The
primary outcome was the rate of dropout. Heterogeneity was
assessed using the I2 statistic and visual inspection of funnel
plots; the Egger weighted meta-regression test was used to
determine the influence of publication bias. If studies are
identified that attempted to prevent dropout, these will form the
basis of a subgroup analysis. A sensitivity analysis was
conducted looking at attrition comparing short (≤2 months)
studies with long (>2 months) studies.
This study was registered at the International Prospective




Use of mHealth solutions in managing chronic conditions is
increasing; however, the effective and long-term engagement
(ie, attrition rate) has been attributed to various factors.
After database searches were performed, a total of 1420 articles
were identified. After excluding duplicates, 831 unique records
remained. Of these, 797 were excluded prior to review. A further
2 records were identified through reference screening from
included studies, leaving a total of 36 studies to be included in
the review (see Figure 1). Of the 36 studies included in the final
review, 19 were excluded based on the exclusion criteria of
studies including children and studies that only looked at acute
or infectious diseases. Studies that were purely online, telephone
and texting interventions, and studies that did not have any
measurement of rates of dropout and attrition were also
excluded. This left 17 studies to be included in the final
qualitative and quantitative synthesis.
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Figure 1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram.
Characteristics of Included Studies
Included studies were published between 2011 and 2019
[14,16-31]. Of these, most (14/17, 82%) examined a range of
chronic diseases, including single studies targeting lower back
pain, chronic kidney disease, pain, dysmenorrhea, and HIV
medications; the remainder (9/17, 53%) looked at more general
lifestyle improvement, such as eating behavior and physical
activity. Out of 17 studies, 3 (18%) that were included in the
review looked specifically at diabetes. There were 9 RCTs
(53%) included in the final synthesis and 8 observational trials
(47%). These are summarized in Table 1.
Studies ranged significantly in duration, size, attrition rate,
methodology, and other areas. The shortest trial included in this
review lasted 2 weeks, and a total of 5 out of 17 (29%) lasted
one month or less. Out of 9 RCTs, 2 (22%) looked at 1 year of
data, and a number of observational trials were conducted over
a period of 6-10 months. The lowest attrition rate in any study
was 9% in an RCT lasting 1 year [29]; the highest attrition rate
was 82% in an observational trial lasting 6 weeks [26]. The
largest trial was an observational study lasting 24 weeks, with
nearly 200,000 participants; the smallest trial was a small cohort
study including just 20 people.
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Table 1. Summary of studies.
Type of studyAttrition
rate









372015A Counselor in Your Pocket: Feasibility of
Mobile Health Tailored Messages to Support
HIV Medication Adherence
Cook et al, [16]
RCTa18%Self-management
support for people
with type 2 diabetes
1512014A Low-Intensity Mobile Health Intervention
With and Without Health Counseling for Per-
sons With Type 2 Diabetes, Part 1: Baseline
and Short-Term Results From a Randomized
Torbjørnsen et al, [17]




3422016A Mobile Phone App Intervention Targeting
Fruit and Vegetable Consumption: The Effica-
cy of Textual and Auditory Tailored Health
Elbert et al, [18]





932018An mHealth App for Self-Management of
Chronic Lower Back Pain (Limbr): Pilot Study





14392018Effect of Self-Monitoring on Long-Term Pa-
tient Engagement With Mobile Health Appli-
cations





202016Effects of Journaling Dietary Intake App on
the Health Outcomes of Chronic Kidney Dis-
ease Stage 3B-5




Mental well-being21612018Efficacy and Moderation of Mobile App-Based
Programs for Mindfulness-Based Training,
Self-Compassion Training, and Cognitive Be-
havioral Psychoeducation on Mental Health:
Randomized Controlled Noninferiority Trial







16,9482015Engagement and Nonusage Attrition With a
Free Physical Activity Promotion Program:
The Case of 10,000 Steps Australia
Guertler et al, [23]
Retrospective
cohort study
86.39%Diet self-monitoring189,7702014Factors Related to Sustained Use of a Free
Mobile App for Dietary Self-Monitoring With
Photography and Peer Feedback: Retrospective
Cohort Study





3182015Identifying Factors Associated With Dropout
During Prerandomization Run-in Period From
an mHealth Physical Activity Education Study:
The mPED Trial
Fukuoka et al, [24]
RCT17.90%Diet behavior2122018Multicomponent mHealth Intervention for
Large, Sustained Change in Multiple Diet and
Spring et al, [25]
Activity Risk Behaviors: The Make Better
Choices 2 Randomized Controlled Trial
RCT81.66%Reduce depressive
symptoms
2832015Randomized Controlled Trial of SuperBetter,
a Smartphone-Based/Internet-Based Self-Help
Tool to Reduce Depressive Symptoms
Roepke et al, [26]
Observational
study
N/AbWeather and pain63702017Recruitment and Ongoing Engagement in a
UK Smartphone Study Examining the Associ-
ation Between Weather and Pain: Cohort Study
Druce et al, [31]
RCT12%Weight loss behavior512016Social Networks for Improving Healthy Weight
Loss Behaviors for Overweight and Obese
Hales et al, [27]
Adults: A Randomized Clinical Trial of the





2212018Effectiveness of App-Based Self-Acupressure
for Women With Menstrual Pain Compared to
Usual Care: A Randomized Pragmatic Trial
Blödt et al, [28]
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Name of the studyAuthor
RCT8.90%Health coaching: dia-
betes and heart dis-
ease patients
5172015Telemonitoring and Mobile Phone-Based
Health Coaching Among Finnish Diabetic and
Heart Disease Patients: Randomized Controlled
Trial
Karhula et al, [29]
RCT21%Self-management
support for people
with type 2 diabetes
1512014A Mobile Health Intervention for Self-Manage-
ment and Lifestyle Change for Persons With
Type 2 Diabetes, Part 2: One-Year Results
From the Norwegian Randomized Controlled
Trial RENEWING HEALTH
Holmen et al, [30]
aRCT: randomized controlled trial.
bN/A: not applicable; this value was not reported.
Meta-Analysis
Results from the meta-analysis are presented in Figure 2. The
average attrition rate overall was 43% (95% CI 29-57), with
very high between-study heterogeneity indicated by an I2
statistic of >99%. The very high heterogeneity is not unexpected
in this case, as studies were extremely varied in terms of time,
implementation, and the disease state that they were examining.
Figure 2. Meta-analysis of attrition rates in app-based intervention studies for chronic disease. ES: effect size.
Looking at the breakdown of results by the type of study, there
was a higher degree of attrition in the observational real-world
studies (49%, 95% CI 27-70) than in the RCTs in more
controlled scenarios, with only 40% (95% CI 16-63) dropping
out. Sensitivity analyses looking at differences in length of study
(ie, short vs long), diabetes versus other chronic diseases, or
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whether the studies were numerically large did not find any
similar differences in attrition rate between trials.
Attrition Rates
One reason associated with lower attrition rates was the
behavioral characteristics of the included participants. Low
attrition rates were characterized by reasons such as the
perception of own health as poor—thus, incentivizing the need
to change [18]—and those who wanted to be involved in their
health care [20]. Other factors that were associated with attrition
in included studies were health literacy; age, with younger
participants dropping out less; and postgraduate education
[18,22]. Very low attrition was also reported among those who
were on strict diets or who had been healthy eaters prior to the
initiation of the study [14]. Another association with low
attrition was with those engaged in multiple interventions. Those
engaged in internet or phone programs as well as apps were
more likely to remain in the research study [23]. Conversely,
there did not appear to be much influence on attrition rates in
terms of length of study, the disease studied, or the size of the
app trial.
Findings from these studies suggest ways to improve attrition
rate and long-term engagement by using varying message
contents or formats to maintain users’ interests; for example,
tailored messages may have the potential to improve adherence
to a clinically significant degree [16]. Other studies suggest less
of a benefit from tailoring messages to maintain users’ interest;
despite a low attrition rate of 22% at 4 months and 1 year in
two studies, respectively, an app and health counseling did not
reduce hemoglobin A1c levels between the intervention and
usual care groups [17,30]. In addition, self-management skills
and the ability to contact health professionals were found to
increase engagement, while users’ feedback input improved
usability of apps and enhanced user experiences for daily
self-reports [17,19]. Classifying different types of users may
be important in improving long-term engagement. Low retention
rate might also be due to an unguided self-help approach, and
further engaging those who need self-monitoring remains
challenging.
Another issue with attrition was that definitions varied
significantly. While some studies reported users who only
logged in a single time as dropouts, others expanded the
definition to include those who only used an app once or twice.
For example, the RCT with the lowest dropout rate overall
included patients who only sent a single report through the app
during the entire follow-up time, which did not indicate
sustained, long-term use [29]. While these users may have been
nondropouts by the definitions used in that study, they had
received significantly lower benefits from the intervention, and




Attrition in app-based interventions is an important and yet
underresearched element. For these interventions to work, it is
a necessary component that people use and continue to use the
app; however, there appears to be evidence that this is not
always the case. In this systematic review and meta-analysis,
the pooled estimate of dropout rates was 43%, with higher rates
seen in real-world research and lower rates in highly supported
RCTs. This may indicate a very serious underlying issue, as
high dropout rates in these interventions will limit their use and
uptake in health care across a range of chronic diseases.
While dropout rates in RCTs were notably lower than in
observational trials, it is worth noting that attrition was often
defined differently in this research. RCTs tended to describe all
participants as users of the app unless they had ceased using it
entirely; while this is in line with best-practice intention-to-treat
analyses, it also presents an important limitation with the pooled
results above. Including people in analyses who have been
randomized is laudable; however, this also obscures the fact
that large proportions of people, even in these randomized trials
with detailed patient support and follow-up, barely used the
app, if at all. This is worrying, because it implies that even with
very high levels of support, apps are not an intervention with
substantial staying power for people with various chronic
diseases. It is also worth recognizing that combining estimates
for both observational and RCT studies may have some
drawbacks, given the differences in study design and participant
retention. However, the difference in reported dropout rates was
not significantly different, with only a small difference in point
estimates and overlapping confidence intervals. This is likely
because the main divergence was in definition of attrition, rather
than the specifics of the study per se. As reported above, even
among RCTs with low rates of dropout, there may have been a
number of studies that would meet the looser definitions of
attrition used in some observational research.
It was also concerning that there does not appear to have been
much examination of the reasons behind this attrition in many
studies. Few studies attempted to explain why people dropped
out, with this being attributed to health literacy, age, and
education, but it is unlikely that these are the only factors that
would be related to attrition in the use of apps. For example, as
mentioned in the results, people whose health saw greater
improvements were more likely in some studies to keep using
the app. It is likely that there are a range of unidentified issues
that could potentially be targeted to ameliorate this problem,
but thus far there has been little recognition of the issue
formally, which may have limited the research that has been
done to remedy the situation. Many studies do not even address
the possibility that people dropping out of an app-based
intervention at alarming rates could be an issue for the
intervention’s adoption at scale, nor do they address the issue
that this could cause in terms of aggravating health inequities
depending on the reasons for dropout. This is especially
concerning when considering that age and social status are likely
to be barriers to app access—as some included studies
hinted—which may further compound the issues caused by
selection bias of those who use apps in the first place. If
younger, healthier people are more likely to use apps overall,
which is often the case [32], and are then more likely to use
them long term, the apps may be less useful for the very
populations that we most want them to help.
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This is a common theme among trials, in which attrition or
nonusage is barely addressed, or only given very surface-level
appraisal. If there is a significant difference in the primary
outcome between the intervention and control groups, there is
a general attitude that the attrition is unimportant; this appears
to be fairly common in RCTs, and may be because the aim of
this research is specifically to evaluate the app in an
intention-to-treat framework [29,30]. However, there are clear
drawbacks to this, not least that we may be seeing a large
underestimate in the literature of the efficacy of app-based
interventions, caused by their generally low use in the
populations who have been studied.
There are a number of very important limitations to this research.
Firstly, the estimates produced are certainly not comprehensive.
Many studies (N>30) that fit all of the inclusion criteria failed
to report dropout or attrition in a way that could be extracted.
Given the number of trials on app-based interventions, it was
not considered feasible to follow up with every author group
that had these figures, but it is worth noting that this best guess
represents a relatively small number of trials within the total
pool of potential evidence.
There is also the issue with heterogeneity. Given the nature of
the included studies, it is not surprising to find very significant
levels of heterogeneity statistically, but it is concerning for the
meta-analysis as a reasonable estimate of attrition. These studies
were conducted across different disease states, with highly
variable interventions; the fact that they all included an app is
a thin bond that did not overcome the vast differences that they
had between them.
It is also worth noting that the research in this space is quickly
evolving. We found no published research to be included before
2010, very little in the years leading up to 2015, and then an
explosion of studies in the years after. It is likely that redoing
this meta-analysis in 2025 will yield a much more reliable
estimate of the figures. This may also allow for analyzing by
disease state, which could prove to be a more accurate estimation
of the rate of attrition.
There are a number of theories that might pertain to attrition in
app-based interventions, with several different focuses. One
area that could help inform attrition research in the future is
behavioral theory, perhaps by examining the sociocognitive
aspects of people who do and do not drop out of app-based
studies. Integrated behavioral theories might also be useful in
examining the relationship between social factors and the
behaviors they cause, to come to an understanding of the process
by which people decide to use or discontinue using apps.
This would ideally tie in to an examination of the broader social
and demographic drivers of attrition. While few of these drivers
have been identified in research so far—age, in particular—there
remains a large evidential gap pertaining to how society
influences behavior to prevent people from using app-based
interventions. Future research should combine these two
theoretical approaches to define the background reasons for
attrition, so that interventions can be designed to minimize it.
Aside from the estimates of app attrition, there are some
important implications of this research. Future studies looking
at app-based interventions should include attrition as a secondary
endpoint and develop methods to prevent it if possible. One
important aspect would be to develop a standard measure of
minimum use in app-based interventions; a reasonable example
is the one used in some of the included trials of one or fewer
log-ins to the app in any given period of time (ie, one log-in per
month). Lower use than this basic threshold could then be
considered attrition for the purposes of research studies. As
well, there should be trials looking at ways to reduce the rate
of dropouts, as well as the potential inequity in the rate of
attrition, in app-based interventions. Without such research, we
have no way of knowing if apps can be effective in the general
population.
Conclusions
This systematic review and meta-analysis found that the pooled
estimate for dropout rates in trials of app-based interventions
for chronic diseases was 43% over a variety of timelines, with
the length of time having little impact on the rate of dropout.
Attrition was higher in observational real-world studies, with
randomized clinical research seeing less than a third of patients
drop out before the trials were completed. However, findings
were limited by high heterogeneity and the lack of reporting in
many trials on attrition rates. Future research should focus on
how often patients drop out and examine reasons why, so that
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